Evidence map›Paper›PMID 38486786›Full record

ArticleHeliyon2024

Near-infrared spectroscopy combined with fuzzy fast pseudoinverse linear discriminant analysis to discriminate mee tea grades.

Bin Wu, Wenbo Tang, Jin Zhou, Hongwen Jia, Hualei Shen, Zuxuan Qi

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bin WuDepartment of Information Engineering, Chuzhou Polytechnic, Chuzhou, 239000, China.
Wenbo TangInstitute of Talented Engineering Students, Jiangsu University, Zhenjiang, 212013, China.
Jin ZhouInstitute of Talented Engineering Students, Jiangsu University, Zhenjiang, 212013, China.
Hongwen JiaDepartment of Information Engineering, Chuzhou Polytechnic, Chuzhou, 239000, China.
Hualei ShenInstitute of Talented Engineering Students, Jiangsu University, Zhenjiang, 212013, China.
Zuxuan QiSchool of Electrical and Information Engineering, Jiangsu University, Zhenjiang, 212013, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mee tea, one of the major types of green tea in China, is often used for export because of its elegant appearance, high fragrance and strong taste. However, the quality of tea differs greatly due to the difference in raw material selection and production technology level. In order to accurately and quickly differentiate different grades of Mee tea, fuzzy fast pseudoinverse linear discriminant analysis (FFPLDA) was proposed based on fast pseudoinverse linear discriminant analysis (FPLDA) for extracting discriminant information from near-infrared (NIR) spectra. Firstly, NIR spectra of Mee tea samples were acquired, and then they were preprocessed by multiplicative scatter correlation (MSC). Secondly, the compression of data was achieved by principal component analysis (PCA). Thirdly, linear discriminant analysis (LDA), FPLDA, FFPLDA and fuzzy Foley-Sammon transformation (FFST) were respectively performed to retrieve discriminant information from NIR data. Finally, the K-nearest neighbor (KNN) was utilized to classify Mee tea grades. In this study, experimental results showed that the accuracy of FFPLDA was higher than that of LDA, FFST and FPLDA. Therefore, NIR spectroscopy coupled with FFPLDA and KNN has a good effect in discrimination of Mee tea grades and also a great application potential.

Indexed as

KNNMee teaNear-infrared spectroscopyPseudoinverse linear discriminant analysis

Identifiers

PMID38486786
PMCPMC10938135

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.